H. Iwase

517 total citations
17 papers, 447 citations indexed

About

H. Iwase is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, H. Iwase has authored 17 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Genetics. Recurrent topics in H. Iwase's work include Estrogen and related hormone effects (6 papers), HER2/EGFR in Cancer Research (4 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). H. Iwase is often cited by papers focused on Estrogen and related hormone effects (6 papers), HER2/EGFR in Cancer Research (4 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). H. Iwase collaborates with scholars based in Japan, United Kingdom and Sweden. H. Iwase's co-authors include Yoshitaka Fujii, Shunzo Kobayashi, Hiroko Yamashita, Tatsuya Toyama, Takao Yamori, Hidetaka Eguchi, Yukio Kobayashi, Shinichi Hayashi, Ken Nakagawa and Yuichi Ishikawa and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

H. Iwase

17 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Iwase Japan 7 239 221 204 124 106 17 447
Mia M. Gaudet United States 5 138 0.6× 141 0.6× 184 0.9× 175 1.4× 121 1.1× 7 418
C S Verrier United States 5 199 0.8× 289 1.3× 346 1.7× 33 0.3× 191 1.8× 7 589
Joanna Matyjasik Poland 7 83 0.3× 154 0.7× 167 0.8× 71 0.6× 95 0.9× 11 316
Elżbieta Złowocka Poland 8 90 0.4× 163 0.7× 170 0.8× 65 0.5× 93 0.9× 9 326
Adrienne R. Hanson Australia 9 106 0.4× 94 0.4× 241 1.2× 175 1.4× 168 1.6× 15 438
Piiha-Lotta Jerevall Sweden 6 143 0.6× 136 0.6× 93 0.5× 77 0.6× 231 2.2× 8 314
Maria Giuseppa Sarobba Italy 10 194 0.8× 63 0.3× 137 0.7× 102 0.8× 147 1.4× 18 344
Beatrice Babbs United States 8 225 0.9× 164 0.7× 230 1.1× 180 1.5× 267 2.5× 9 517
Hari Singhal United States 8 124 0.5× 177 0.8× 155 0.8× 49 0.4× 83 0.8× 13 336
Peng Xing China 9 146 0.6× 62 0.3× 94 0.5× 27 0.2× 95 0.9× 20 314

Countries citing papers authored by H. Iwase

Since Specialization
Citations

This map shows the geographic impact of H. Iwase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Iwase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Iwase more than expected).

Fields of papers citing papers by H. Iwase

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Iwase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Iwase. The network helps show where H. Iwase may publish in the future.

Co-authorship network of co-authors of H. Iwase

This figure shows the co-authorship network connecting the top 25 collaborators of H. Iwase. A scholar is included among the top collaborators of H. Iwase based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Iwase. H. Iwase is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Kinoshita, T., Norikazu Masuda, Yasuaki Sagara, et al.. (2011). Neoadjuvant anastrozole or tamoxifen for premenopausal breast cancer: Ki67 expression data from the STAGE study.. Journal of Clinical Oncology. 29(15_suppl). 501–501. 1 indexed citations
3.
Yamashita, Hiroko, Mariko Nishio, Tatsuya Toyama, et al.. (2008). Low phosphorylation of estrogen receptor   (ER ) serine 118 and high phosphorylation of ER  serine 167 improve survival in ER-positive breast cancer. Endocrine Related Cancer. 15(3). 755–763. 75 indexed citations
4.
Yamamoto, Yuki, Mutsuko Ibusuki, Masahiro Nakano, et al.. (2008). Basal cell-like signature is an independent prognostic factor in triple-negative breast cancer. Journal of Clinical Oncology. 26(15_suppl). 22184–22184. 1 indexed citations
5.
Iwase, H., et al.. (2008). Multicenter phase II study of triple combination with S-1 and cisplatin (CDDP) plus paclitaxel (TXL) in patients with advanced gastric cancer. Journal of Clinical Oncology. 26(15_suppl). 4539–4539. 2 indexed citations
6.
Watanabe, H., H. Iwase, Masahiko Sugitani, & Tomoo Watanabe. (2005). Compression of the common bile duct by the posterosuperior pancreaticoduodenal artery: case report. Abdominal Imaging. 30(2). 214–217. 2 indexed citations
7.
Iwase, H., Masaaki Shimada, Tomoyuki Tsuzuki, et al.. (2005). A phase II multicentric trial of S-1 combined with24 h-infusion of cisplatin in patients with advanced gastric cancer. Journal of Clinical Oncology. 23(16_suppl). 4055–4055. 2 indexed citations
8.
Kobayashi, Yukio, Hidetaka Eguchi, Ken Nakagawa, et al.. (2001). Expression, Function, and Clinical Implications of the Estrogen Receptor β in Human Lung Cancers. Biochemical and Biophysical Research Communications. 285(2). 340–347. 175 indexed citations
9.
10.
Iwase, H., et al.. (1999). Clinical significance of estrogen receptor β in breast cancer. Breast Cancer. 6(4). 325–330. 3 indexed citations
11.
Iwase, H., et al.. (1998). Genetic and Epigenetic Alterations of the Estrogen Receptor Gene and Hormone Independence in Human Breast Cancer. Oncology. 55(Suppl. 1). 11–16. 15 indexed citations
12.
Iwase, H.. (1998). [Clinical value of gene diagnosis in breast cancer].. PubMed. 46(9). 869–75. 1 indexed citations
13.
Iwase, H., et al.. (1997). The clinical value of microsatellite instability and a loss in heterozygosity in sporadic breast cancers. Breast Cancer. 4(4). 234–238. 5 indexed citations
14.
15.
Toyama, Tatsuya, H. Iwase, Hiroko Yamashita, et al.. (1996). Microsatellite instability in sporadic human breast cancers. International Journal of Cancer. 68(4). 447–451. 52 indexed citations
16.
Yamashita, Hiroko, Shunzo Kobayashi, H. Iwase, et al.. (1993). Analysis of Oncogenes and Tumor Suppressor Genes in Human Breast Cancer. Japanese Journal of Cancer Research. 84(8). 871–878. 33 indexed citations
17.
Kobayashi, Shunzo, et al.. (1992). Estrogen Receptor, c‐erbB‐2 and nm23/NDP Kinase Expression in the Intraductal and Invasive Components of Human Breast Cancers. Japanese Journal of Cancer Research. 83(8). 859–865. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mia M. Gaudet Breakdown of academic impact, for papers by C S Verrier Breakdown of academic impact, for papers by Joanna Matyjasik Breakdown of academic impact, for papers by Elżbieta Złowocka Breakdown of academic impact, for papers by Adrienne R. Hanson Breakdown of academic impact, for papers by Piiha-Lotta Jerevall Breakdown of academic impact, for papers by Maria Giuseppa Sarobba Breakdown of academic impact, for papers by Beatrice Babbs Breakdown of academic impact, for papers by Hari Singhal Breakdown of academic impact, for papers by Peng Xing
Rankless by CCL
2026